Healthcare Stocks

Flu Season Is Coming — And These Companies Are Ready

Flu season is slowly getting started -- bad news for us, but welcome news for companies that benefit from flu sufferers' ills. Here's a look at some of them. More 

Obamacare Won’t Deliver — Sell Hospital and Managed Care Stocks, STAT!

By Jeff Reeves -- Obamacare might never deliver on the hopes of perpetually higher healthcare stock prices, and many bid-up companies could end up disappointing shareholders. More 

Medical Device Companies Still Have Upside, New Tax or Not

By Dan Burrows -- A sales tax on medical devices under Obamacare has spooked investors in medical device companies, but behemoths like Medtronic and Stryker will shrug it off. More 

2 Top Healthcare Stock Picks for Obamacare

By Louis Navellier -- The Affordable Care Act (aka Obamacare) will improve the prospects of these two healthcare stocks. More 

How to Invest in Obamacare-Era Healthcare

By Charles Sizemore -- In the complex post-Obamacare medical landscape, keep your investing simple. Stick with hospital stocks and avoid insurance stocks. More 

Trade of the Day: Tenet Healthcare (THC)

The new health insurance exchanges go live on Oct. 1, and there are still a lot of unknowns. Healthcare stocks are likely to see bearishness short term. More 

Google Bets on Healthcare — You Should, Too

Google is aiming at helping humans live longer via a new venture, Calico -- another nod at just how lucrative the healthcare space should continue to be. More 

Trade of the Day: Tenet Healthcare (THC)

Upcoming political budget battles could cause significantly more problems, so holding bearish positions also makes sense. More 

3 Companies With a Headstart on Healthcare Reform

Lowering healthcare costs is a huge theme as the insurance exchanges are about to open, and these 3 companies have taken innovation into their own hands. More 

4 Healthcare Investments to Make Before October

With open enrollment in state health insurance exchanges set to kick off on Oct. 1, it’s a good time to revisit the ways investors can play the opportunity. More